Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00973921 · ClinicalTrials.gov registry record

Comparison of StentOptimizer With IntraVenous Ultrasound and 2D Quantitative Coronary Angiography

A clinical trial of Coronary Artery Disease, sponsored by Paieon.

Completed
Registry status
40
Enrollment target
1
Study location

NCT00973921: Completed study of Coronary Artery Disease, sponsored by Paieon.

NCT00973921 is a study of Coronary Artery Disease that has completed, run by Paieon. The registered enrollment target is 40 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00973921, a study of Coronary Artery Disease, has completed, sponsored by Paieon.

COMPLETED
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to determine the diagnostic efficiency and accuracy of using the StentOptimizer. The ability of StentOptimizer to influence post deployment treatment strategy will be assessed and compared to the IVUS system. In addition, the correlation of diameter measurements between the StentOptimizer, IVUS and 2D QCA will be assessed. The StentOptimizer software, IVUS and 2D QCA were all part of the clinical procedure outside the study. The analysis of post deployment treatment decisions and diameter measurements using those modalities retrospectively make this an observational study.

Primary Outcome

IVUS was used as a gold standard to decide if a stent required post dilatation or not. Independently and blindly, The SO software was used to determine the same decisions. The accuracy of SO was determined as the percentage of correct decisions compared to the gold standard.

Conditions Studied

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2009-09
Est. Completion 2010-03
Paieon

1 total trials

What the finished NCT00973921 record still lists

NCT00973921 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00973921 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00973921 about?

NCT00973921 is a clinical study titled "Comparison of StentOptimizer With IntraVenous Ultrasound and 2D Quantitative Coronary Angiography". The primary objective of this study is to determine the diagnostic efficiency and accuracy of using the StentOptimizer. The ability of StentOptimizer to influence post deployment treatment strategy will be assessed and compared to the IVUS system. In addition, the correlation of diameter measurement...

What is the current status of trial NCT00973921?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2009-09. Estimated completion is 2010-03.

What conditions does trial NCT00973921 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

Who is sponsoring clinical trial NCT00973921?

This trial is sponsored by Paieon, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00973921 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00973921's enrollment target sits among peer trials

40 188th of 219 higher than 27 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00973921, the US trial registry maintained by the National Library of Medicine. NCT00973921 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.